• Capricor Therapeutics (NASDAQ:CAPR) Stock Rating Lowered by Zacks Investment Research

    Capricor Therapeutics (NASDAQ:CAPR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report …

    Read More
  • 0 0